Skip to main content

August 2014

 

 

academics

 

Clinical research courses

Job in Oxagon Pharmaceuticals for the post of Marketing Executive/ Medical Representative

We are Marketing, Distribution firm. We are having products of Ortho, Gynac and Paediatric Division. We are also having distribution of Generic products of Abbott, Alkem, Medley, Laborate, Biogem, Rochchem and many more.

Post: Marketing Executive/ Medical Representative

Career for B.Sc, D.Pharm, B.Pharm as Medical Representative & Area Manager in Diagnose Pharma

Diagnose Pharma was established in 2013. Diagnose pharma is an organization handled by skilled experts highly qualified inside their particular subject of operations. We are here to provide solution to patients and community. Our main aim behind this initiative is to provide good health to people, so there lives become happy and healthy.

Post: Medical Representative & Area Manager

Hospira looking for Diploma in Pharmacy as Officer - Warehouse

Hospira is the world's leading provider of injectable drugs and infusion technologies. Through our broad, integrated portfolio, we are uniquely positioned to Advance Wellness™ by improving patient and caregiver safety while reducing healthcare costs.
Through our offering of high-quality, lower-cost generic medications, we continue to help reduce the overall costs of healthcare — to improve both the affordability of care for patients and the financial strength of the global healthcare system.

Post: Officer - Warehouse

Opportunity for Validation Analyst in Icon Clinical Research

ICON is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. We specialize in the strategic development, management and analysis of programs that support Clinical Development – from compound selection to Phase I - IV clinical studies
ICON enjoys a strong reputation for quality and is focused on staff development. We make it our mission to attract the most diverse and creative minds into the business and we continually strive to provide opportunities for our people to excel, grow and build a great career. We understand that our greatest asset is the skills and talents of our people and they are truly what set us apart.

Post: Validation Analyst

Applications are invited from M.Pharm for UGC-BSR Research Fellow in BIT, Mesra

BIT, Mesra is a "Deemed University" under Sec. 3 of the U.G.C. Act 1956. The Board of Governors is responsible for the main functions and overall supervision of activities. It comprises representatives of the Ministry of Education, Government of India, the U.G.C., the State Government, The Chancellor, the AICTE, The Hindustan Charity Trust and the Institute Faculty. Shri C.K. Birla is the Chairman of the Board of Governors while the Governor of the state of Jharkhand officiates as the Institute's Chancellor.  There's a Technical Council that decides the academic policy of the Institute.

Applications are invited for Research Fellowships at the Department of Pharmaceutical Science & Technology, Birla Institute of Technology, Mesra under the scheme of “UGC-BSR Research Fellowships”.

Post: UGC-BSR Research Fellow

Regulatory Affairs Associate in Novo Nordisk - experience candidates only

Novo Nordisk is a global healthcare company with 89 years of innovation and leadership in diabetes care. The company also has leading positions within Haemophilia care, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs approximately 33,300 employees in 75 countries, and markets its products in more than 190 countries Novo Nordisk’s B shares are listed on NASDAQ OMX Copenhagen (Novo-B).

Post: RA Associate-III

(6th August, 2014); Sanofi in India announced today that it has entered into a marketing and distribution agreement with Emcure Pharmaceuticals (Emcure) for its oncology portfolio in India. As per the agreement, while Sanofi will continue to own its oncology range - comprising 4 brands namely Taxotere®, Jevtana®, Fludara® and Fasturtec®, Emcure will market and distribute these brands through its Specialty Unit.

(6th August, 2014); Roche announced on last Monday that it has agreed to acquire Santaris Pharma, a privately held biopharmaceutical company based near Copenhagen, Denmark. Santaris Pharma has pioneered its proprietary Locked Nucleic Acid (LNA) platform that has contributed to an emerging era of RNA-targeting therapeutics. This new class of medicines has the potential to address difficult to treat diseases in a range of therapeutic areas.

(6th August, 2014); Central Drugs Standard Control Organization (CDSCO) ensuring uniform procedures in regulatory inspection for issuance of Certificates of Pharmaceutical Products (COPP) and other Good Manufacturing Practices (GMP) inspections. These procedures were discussed in 47th Drugs consultative committee (DCC) meeting.